MedTrace Logo

Non-interventional Study of Ectoin Nasal Douche (END01) in Patients With Acute Viral Rhinosinusitis

NCT03480100 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2018-07-11

No results posted yet for this study

Summary

The goal of this non interventional study is to investigate the efficacy, tolerability and safety of the newly developed Ectoin Nasal Douche END01. Within the study, END01 will be used as concomitant therapy in addition to the use of a Xylometazoline-containing decongestant nasal spray.

It will be investigated if the dosis of the used decongestant nasal spray might be reduced, the development of the disease might be positively influenced and/or the potentially occuring side effects (e.g. dryness of the nasal mucosa, sneezing) might be alleviated by using the Ectoin Nasal Douche as concomitant therapy.

Conditions

  • Acute Rhinosinusitis

Interventions

DRUG

Xylometazoline Nasal Spray

Application of Xylometazoline Nasal Spray in accordance with the instructions for use

DEVICE

Ectoin Nasal Douche

Application of Ectoin Nasal Douche (END01) in accordance with the instructions for use

Sponsors & Collaborators

  • Bitop AG

    lead INDUSTRY

Principal Investigators

  • Andreas Bilstein, Dr. · CSO

Eligibility

Min Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-27
Primary Completion
2018-05-31
Completion
2018-05-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03480100 on ClinicalTrials.gov